Is treatment for myeloma successful? The short answer is: yes, often very much so — and it keeps getting better!
More than 90 percent of people respond well to their first round of treatment, meaning the cancer shrinks or becomes less active. On average, people are disease-free (in remission) for about four years after Show Full Answer
Is treatment for myeloma successful? The short answer is: yes, often very much so — and it keeps getting better!
More than 90 percent of people respond well to their first round of treatment, meaning the cancer shrinks or becomes less active. On average, people are disease-free (in remission) for about four years after their first treatment. Here are some encouraging highlights from recent research:
- A combination of talquetamab, daratumumab, and pomalidomide helped 82% of people with relapsed or hard-to-treat myeloma respond to treatment
- CAR T-cell therapy reduced the risk of death by 45% in certain patients
- Adding daratumumab to an existing drug combination helped more newly diagnosed patients achieve no detectable cancer cells
The five-year survival rate is around 61-62%, and that number continues to improve as new treatments are developed. While myeloma isn't considered curable for most people, many live long, fulfilling lives managing it as a chronic condition. Treatment plans are highly personalized, and your oncology team will work with you to find the best approach for your specific situation.
July 26
Join
Your Privacy Choices
